Form 8-K - Current report:
SEC Accession No. 0001193125-24-227977
Filing Date
2024-09-27
Accepted
2024-09-27 16:17:01
Documents
21
Period of Report
2024-09-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d856255d8k.htm   iXBRL 8-K 42376
2 EX-1.1 d856255dex11.htm EX-1.1 193062
3 EX-4.1 d856255dex41.htm EX-4.1 58094
4 EX-4.2 d856255dex42.htm EX-4.2 80571
5 EX-5.1 d856255dex51.htm EX-5.1 13707
6 EX-99.1 d856255dex991.htm EX-99.1 11125
10 GRAPHIC g856255g0927121153692.jpg GRAPHIC 2240
11 GRAPHIC g856255g0927121321972.jpg GRAPHIC 3190
12 GRAPHIC g856255g0927153317974.jpg GRAPHIC 4983
  Complete submission text file 0001193125-24-227977.txt   643306

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA cue-20240926.xsd EX-101.SCH 2862
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cue-20240926_lab.xml EX-101.LAB 17235
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cue-20240926_pre.xml EX-101.PRE 10821
24 EXTRACTED XBRL INSTANCE DOCUMENT d856255d8k_htm.xml XML 3525
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 241335092
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)